536565
TRIMURTHI
Start SIP
Invest Now
Start SIP in TRIMURTHI
Performance
- Low
- ₹56
- High
- ₹60
- 52 Week Low
- ₹24
- 52 Week High
- ₹70
- Open Price₹56
- Previous Close₹58
- Volume7,285
Investment Returns
- Over 1 Month + 2.83%
- Over 3 Month + 44.09%
- Over 6 Month + 100.89%
- Over 1 Year + 143.98%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 98
- PEG Ratio
- 0
- Market Cap Cr
- 95
- P/B Ratio
- Average True Range
- 3.55
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.43
- RSI
- 48.8
- MFI
- 48.2
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
Current Price
₹58.92
+
0.49
(0.84%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹58.96
- 50 Day
- ₹55.35
- 100 Day
- ₹49.37
- 200 Day
- ₹40.15
Resistance and Support
57.86
- R3 63.61
- R2 61.76
- R1 59.71
- S1 55.81
- S2 53.96
- S3 51.91
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & A.G.M. | |
| 2025-06-24 | Others | Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company. |
| 2025-05-27 | Audited Results | |
| 2025-04-12 | Others | Inter-alia, to consider 1. Convening of an EGM for appointment of Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for the upcoming EGM. 3. Other business matters. |
Novelix Pharmaceuticals F&O
About Novelix Pharmaceuticals
- NSE Symbol
- TRIMURTHI
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹58 As on 24 December, 2025 | 18:04
The Market Cap of Novelix Pharmaceuticals is ₹95.1 Cr As on 24 December, 2025 | 18:04
The P/E ratio of Novelix Pharmaceuticals is 98 As on 24 December, 2025 | 18:04
The PB ratio of Novelix Pharmaceuticals is 3.5 As on 24 December, 2025 | 18:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.